DWA
TCON

Dorsey Wright & Associates’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Dorsey Wright & Associates’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-89
Closed -$21K – 384
2020
Q4 		$21K Buy
+89
New +$12.4K ﹤0.01% 179

Other funds holding TCON

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Dorsey Wright & Associates's TCON Position: Q1 2021 in Review

Dorsey Wright & Associates sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q1 2021, closing a stake of 89 shares — an estimated $21K sold.

Dorsey Wright & Associates first reported a position in TCON in Q4 2020 and held it in 1 quarter. The position peaked at $21K in Q4 2020. 42 funds tracked by Wall St. Rank hold TCON as of Q1 2021.

  • Dorsey Wright & Associates reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 89 TRACON Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $21K.
  • Dorsey Wright & Associates first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Dorsey Wright & Associates's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $21K in Q4 2020.
  • 42 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on Dorsey Wright & Associates's 13F filing for Q1 2021, filed 27 Apr 2021.